Abstract
Objectives
The purpose of this study is to establish microvascular invasion (MVI) prediction models based on preoperative contrast-enhanced ultrasound (CEUS) and ethoxybenzyl-enhanced magnetic resonance imaging (EOB-MRI) in patients with a single hepatocellular carcinoma (HCC) ≤ 5 cm.
Methods
Patients with a single HCC ≤ 5 cm and accepting CEUS and EOB-MRI before surgery were enrolled in this study. Totally, 85 patients were randomly divided into the training and validation cohorts in a ratio of 7:3. Non-radiomics imaging features, the CEUS and EOB-MRI radiomics scores were extracted from the arterial phase, portal phase and delayed phase images of CEUS and the hepatobiliary phase images of EOB-MRI. Different MVI predicting models based on CEUS and EOB-MRI were constructed and their predictive values were evaluated.
Results
Since univariate analysis revealed that arterial peritumoral enhancement on the CEUS image, CEUS radiomics score, and EOB-MRI radiomics score were significantly associated with MVI, three prediction models, namely the CEUS model, the EOB-MRI model, and the CEUS-EOB model, were developed. In the validation cohort, the areas under the receiver operating characteristic curve of the CEUS model, the EOB-MRI model, and the CEUS-EOB model were 0.73, 0.79, and 0.86, respectively.
Conclusions
Radiomics scores based on CEUS and EOB-MRI, combined with arterial peritumoral enhancement on CEUS, show a satisfying performance of MVI predicting. There was no significant difference in the efficacy of MVI risk evaluation between radiomics models based on CEUS and EOB-MRI in patients with a single HCC ≤ 5 cm.
Clinical relevance statement
Radiomics models based on CEUS and EOB-MRI are effective for MVI predicting and conducive to pretreatment decision-making in patients with a single HCC within 5 cm.
Key Points
• Radiomics scores based on CEUS and EOB-MRI, combined with arterial peritumoral enhancement on CEUS, show a satisfying performance of MVI predicting.
• There was no significant difference in the efficacy of MVI risk evaluation between radiomics models based on CEUS and EOB-MRI in patients with a single HCC ≤ 5 cm.
Similar content being viewed by others
Abbreviations
- AFP:
-
Alpha-fetoprotein
- AP:
-
Arterial phase
- AUROC:
-
Area under the receiver operating characteristic curve
- CEUS:
-
Contrast-enhanced ultrasound
- DP:
-
Delayed phase
- EOB-MRI:
-
Ethoxybenzyl-enhanced magnetic resonance imaging
- Gd-EOB-DTPA:
-
Gadolinium ethoxybenzyl diethylene-triaminepentaacetic acid
- HBP:
-
Hepatobiliary phase
- HBV:
-
Hepatitis B virus
- HCC:
-
Hepatocellular carcinoma
- MVI:
-
Microvascular invasion
- NPV:
-
Negative predictive value
- PP:
-
Portal phase
- PPV:
-
Positive predictive value
- Sen:
-
Sensitivity
- Spe:
-
Specificity
References
Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314
Villanueva A (2019) Hepatocellular Carcinoma. N Engl J Med 380:1450–1462
Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20:325–339
Zhang X, Li J, Shen F, Lau WY (2018) Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 33:347–354
Lim KC, Chow PK, Allen JC et al (2011) Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 254:108–113
Court CM, Harlander-Locke MP, Markovic D et al (2017) Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection. Liver Transpl 23:1123–1132
Szpakowski JL, Drasin TE, Lyon LL (2017) Rate of seeding with biopsies and ablations of hepatocellular carcinoma: a retrospective cohort study. Hepatol Commun 1:841–851
Yamashita Y, Tsuijita E, Takeishi K et al (2012) Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm. Ann Surg Oncol 19:2027–2034
Hirokawa F, Hayashi M, Miyamoto Y et al (2014) Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res 44:846–853
Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43
Ueno M, Hayami S, Shigekawa Y et al (2015) Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: cohort study based on serum HCC markers. J Hepatol 63:1352–1359
Lee S, Kang TW, Song KD et al (2021) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg 273:564–571
Lei Z, Li J, Wu D et al (2016) Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan Criteria. JAMA Surg 151:356–363
Ma X, Wei J, Gu D et al (2019) Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol 29:3595–3605
Cao L, Chen J, Duan T et al (2019) Diffusion kurtosis imaging (DKI) of hepatocellular carcinoma: correlation with microvascular invasion and histologic grade. Quant Imaging Med Surg 9:590–602
Xu X, Zhang HL, Liu QP et al (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70:1133–1144
Qu C, Wang Q, Li C et al (2022) A radiomics model based on Gd-EOB-DTPA-enhanced MRI for the prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm. Front Oncol 12:831795
Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380
Wilson SR, Lyshchik A, Piscaglia F et al (2018) CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY) 43:127–142
Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534
Chong HH, Yang L, Sheng RF et al (2021) Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm. Eur Radiol 31:4824–4838
Yang L, Gu D, Wei J et al (2019) A radiomics nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Liver Cancer 8:373–386
Dietrich CF, Nolsøe CP, Barr RG et al (2020) Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med 41:562–585
Huang J, Tian W, Zhang L et al (2020) Preoperative prediction power of imaging methods for microvascular invasion in hepatocellular carcinoma: a systemic review and meta-analysis. Front Oncol 10:887
Zhong X, Peng J, Xie Y et al (2022) A nomogram based on multi-modal ultrasound for prediction of microvascular invasion and recurrence of hepatocellular carcinoma. Eur J Radiol 151:110281
Feng ST, Jia Y, Liao B et al (2019) Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol 29:4648–4659
Zhong X, Long H, Su L et al (2022) Radiomics models for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis. Abdom Radiol (NY) 47:2071–2088
Nishie A, Yoshimitsu K, Asayama Y et al (2008) Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol 190:81–87
Renzulli M, Brocchi S, Cucchetti A et al (2016) Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiology 279:432–442
Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50
Efremidis SC, Hytiroglou P (2002) The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 12:753–764
Zhang S, Xu G, Duan C et al (2021) Radiomics analysis of MR imaging with Gd-EOB-DTPA for preoperative prediction of microvascular invasion in hepatocellular carcinoma: investigation and comparison of different hepatobiliary phase delay times. Biomed Res Int 2021:6685723
Yang J, Jiang H, Xie K et al (2022) Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: an intra-individual comparative study based on the Liver Imaging Reporting and Data System. Eur J Radiol 154:110397
Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 34:11–29
Hong SB, Choi SH, Kim SY et al (2021) MRI features for predicting microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer 10:94–106
Kim H, Park MS, Choi JY et al (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744–1751
Wu Y, Zhu M, Liu Y, Cao X, Zhang G, Yin L (2022) Peritumoral imaging manifestations on Gd-EOB-DTPA-enhanced MRI for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis. Front Oncol 12:907076
Funding
This work was supported by the National Natural Science Foundation of China (Grant No. 92059201).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Guarantor
The scientific guarantor of this publication is Guangliang Huang.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
No study subjects or cohorts have been previously reported.
Methodology
-
retrospective
-
diagnostic or prognostic study
-
performed at one institution
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zheng, R., Zhang, X., Liu, B. et al. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm. Eur Radiol 33, 6462–6472 (2023). https://doi.org/10.1007/s00330-023-09789-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-09789-5